Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688050's Gross Margin % is ranked better than 66.46% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.16
vs SHSE:688050: 62.71
Eyebright Medical Technology (Beijing) Co had a gross margin of 61.48% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Eyebright Medical Technology (Beijing) Co (SHSE:688050) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Eyebright Medical Technology (Beijing) Co had a gross margin of 61.48% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Eyebright Medical Technology (Beijing) Co Gross Margin % Related Terms
Eyebright Medical Technology (Beijing) Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eyebright Medical Technology (Beijing) Co Gross Margin % Chart
Eyebright Medical Technology (Beijing) Co Annual Data
SHSE:688050 vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Eyebright Medical Technology (Beijing) Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eyebright Medical Technology (Beijing) Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eyebright Medical Technology (Beijing) Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Eyebright Medical Technology (Beijing) Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Eyebright Medical Technology (Beijing) Co (SHSE:688050) has a Gross Margin % of 61.48% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Eyebright Medical Technology (Beijing) Co and its competitors. This is 22% below median its historical median of 78.52. Over the past decade, Eyebright Medical Technology (Beijing) Co's Gross Margin % has ranged from 62.71 to 85.69. According to the industry distribution chart, Eyebright Medical Technology (Beijing) Co ranks #270 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 33.5%.
Is Eyebright Medical Technology (Beijing) Co's Gross Margin % too high?
Eyebright Medical Technology (Beijing) Co's current Gross Margin % of 61.48% is 22% below median its 10-year median of 78.52. Over the past 10 years, this metric has ranged from a low of 62.71 to a high of 85.69. The Medical Devices & Instruments industry median Gross Margin % is 52.16. Eyebright Medical Technology (Beijing) Co's value of 61.48% is 17.9% above this industry median. Based on the distribution chart, Eyebright Medical Technology (Beijing) Co ranks #270 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Eyebright Medical Technology (Beijing) Co has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Eyebright Medical Technology (Beijing) Co's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Eyebright Medical Technology (Beijing) Co ranks #270 out of 805 companies for Gross Margin %. This puts Eyebright Medical Technology (Beijing) Co in the upper half of its industry. The industry median Gross Margin % is 52.16. Eyebright Medical Technology (Beijing) Co's value of 61.48% is 17.9% above this benchmark. Historically, Eyebright Medical Technology (Beijing) Co's own Gross Margin % has ranged from 62.71 to 85.69 over the past decade. While the company's 10-year median is 78.52 vs. the industry median of 52.16, Eyebright Medical Technology (Beijing) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.16, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eyebright Medical Technology (Beijing) Co's current Gross Margin % of 61.48% is 17.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Eyebright Medical Technology (Beijing) Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eyebright Medical Technology (Beijing) Co's current Gross Margin % is 61.48%, which is 22% below median its own 10-year median of 78.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eyebright Medical Technology (Beijing) Co stock overvalued right now?
Based on GuruFocus' analysis, Eyebright Medical Technology (Beijing) Co (SHSE:688050) is currently considered Possible Value Trap. The stock's GF Value™ is ¥112.14, compared to a current price of ¥41.49 — trading 63% below its estimated fair value. The current Gross Margin % is 61.48%, which is 22% below median its 10-year median of 78.52 and 17.9% above the Medical Devices & Instruments industry median of 52.16. Eyebright Medical Technology (Beijing) Co's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Eyebright Medical Technology (Beijing) Co (SHSE:688050), the current Gross Margin % is 61.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eyebright Medical Technology (Beijing) Co (SHSE:688050) Overvalued in 2026?
Based on GuruFocus' analysis, Eyebright Medical Technology (Beijing) Co stock appears to be undervalued.
The current stock price of ¥41.49 is trading 63% below its estimated GF Value™ of ¥112.14.
GuruFocus considers Eyebright Medical Technology (Beijing) Co to be Possible Value Trap.
Key valuation signals for SHSE:688050:
Gross Margin %: 61.48% (22% below median its 10-year median of 78.52)
GF Value™: ¥112.14 vs. price of ¥41.49 (63% below fair value)
Industry Position: 17.9% above the Medical Devices & Instruments median (#270 of 805)
No single metric tells the full story. See the SHSE:688050 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eyebright Medical Technology (Beijing) Co Business Description
Eyebright Medical Technology (Beijing) Co Ltd is engaged in research and development, production, sales and related services of ophthalmic medical devices. The company's product range includes Intraocular Lens; IOL Delivery System; Ophthalmic Instruments; Other Products; Literature; and Expert Interview.
74GF Score
Get the complete analysis for SHSE:688050
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688050 has been successfully added to your 
